Literature DB >> 10940554

Genomic organization and chromosome localization of the newly identified human heparanase gene.

J Dong1, A K Kukula, M Toyoshima, M Nakajima.   

Abstract

Heparanase (HPSE), which we have recently isolated, is an endo-beta-D-glucuronidase capable of cleaving heparan sulfate and has been implicated in inflammation and tumor angiogenesis and metastasis. In this report, the genomic organization and chromosome localization of the human heparanase gene is described. Polymerase chain reaction, subcloning and DNA sequencing analysis of a bacterial artificial chromosome (BAC) clone revealed that the 3.7 kb human heparanase cDNA is spread over about 50 kb and contains 14 exons and 13 introns. The heparanase gene is expressed as two mRNA species containing the same open reading frame, HPSE 1a (5 kb) (GenBank Data Library under accession number: AF155510); and HPSE 1b (1.7 kb) (GenBank Data Library under accession number: AF144325), generated by alternative splicing. The HPSE 1a-form contains all 14 exons, whereas in the HPSE 1b-form the first and fourteenth exons (5'- and 3'-untranslated region) have been spliced out. All splice sites conform to the GT-AG rule, except for the splice donor site of intron 13 (which is GA instead of GT), and the splice acceptor of intron 13 (which is GG instead of AG). Fluorescence in situ hybridization and radiation hybrid mapping suggest that the heparanase gene is located on human chromosome 4q22. This report regarding the structure of the human heparanase gene will aid in understanding the genetic contribution of this gene to normal physiology as well as to disease states. A possible involvement of heparanase in neuronal degeneration is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940554     DOI: 10.1016/s0378-1119(00)00251-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Efficient use of a 'dead-end' GA 5' splice site in the human fibroblast growth factor receptor genes.

Authors:  Simon Brackenridge; Andrew O M Wilkie; Gavin R Screaton
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

3.  Cloning, expression, and characterization of an alternatively spliced variant of human heparanase.

Authors:  Nicola J Nasser; Aaron Avivi; Moran Shushy; Israel Vlodavsky; Eviatar Nevo
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

4.  Characterization of Arabidopsis AtUGT85A and AtGUS gene families and their expression in rapidly dividing tissues.

Authors:  Ho-Hyung Woo; Byeong Ryong Jeong; Ann M Hirsch; Martha C Hawes
Journal:  Genomics       Date:  2007-05-10       Impact factor: 5.736

5.  Inhibition of heparanase protects against pancreatic beta cell death in streptozotocin-induced diabetic mice via reducing intra-islet inflammatory cell infiltration.

Authors:  Wen-Yu Song; Xiao-Han Jiang; Ying Ding; Yan Wang; Ming-Xuan Zhou; Yun Xia; Chen-Yu Zhang; Chong-Chong Yin; Chen Qiu; Kai Li; Peng Sun; Xiao Han
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

6.  Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant.

Authors:  Nicola J Nasser; Eviatar Nevo; Itay Shafat; Neta Ilan; Israel Vlodavsky; Aaron Avivi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-04       Impact factor: 11.205

Review 7.  Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis.

Authors:  E Zcharia; S Metzger; T Chajek-Shaul; Y Friedmann; O Pappo; A Aviv; M Elkin; I Pecker; T Peretz; I Vlodavsky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

Review 8.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

9.  Heparanase mRNA expression and point mutation in hepatocellular carcinoma.

Authors:  Xiao-Peng Chen; Yin-Bib Liu; Jing Rui; Shu-You Peng; Cheng-Hong Peng; Zi-Yan Zhou; Liang-Hui Shi; Hong-Wei Shen; Bin Xu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

10.  Two heparanase splicing variants with distinct properties are necessary in early Xenopus development.

Authors:  Gabriel E Bertolesi; George Michaiel; Sarah McFarlane
Journal:  J Biol Chem       Date:  2008-04-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.